Technological Advances in the Assessment and Treatment of Addiction

OLLI and the WVU Committee of Retired Faculty will host "Technological Advances in the Assessment and Treatment of Addiction," a lecture by Dr. James J. Mahoney, on Wednesday, June 4, at 2:30 p.m. in OLLI classroom B at the Mountaineer Mall and on Zoom.

Dr. Mahoney will discuss the early findings from clinical trials conducted at West Virginia University and the Rockefeller Neuroscience Institute, involving neuromodulation for addiction. He will also discuss other technologies developed by WVU/RNI, such as population health digital infrastructure that utilizes wearable technology and other health data, combined with machine learning, to monitor, identify, and predict risk factors associated with drug relapse.

James J. Mahoney, III, Ph.D., is an Associate Professor and Clinical Neuropsychologist in the Department of Behavioral Medicine and Psychiatry and the Department of Neuroscience at the Rockefeller Neuroscience Institute (RNI) and West Virginia University (WVU) School of Medicine. Dr. Mahoney is currently the Director of Addictions Research at the RNI and previously served as Chair of the Research Oversight Committee in his primary department. Prior to joining WVU, Dr. Mahoney completed his doctoral training at the University of Houston and specialized post-doctoral training in neuropsychology at the University of Virginia. He has accumulated over 20 years of research experience, most of which has focused on the assessment and treatment of substance use disorders. Dr. Mahoney has co-authored 81 peer-reviewed manuscripts (32 first/senior authored), has published several book chapters, and has presented original research findings at several international conferences. Dr. Mahoney has served as co-investigator on several NIDA and NIGMS-funded proposals. Dr. Mahoney’s specific areas of research focus include the investigation of various forms of neuromodulation, such as deep brain stimulation, focused ultrasound, and transcranial magnetic stimulation for the treatment of substance use disorders and other behavioral/psychiatric indications.  

The lecture is free and open to the public. Advance registration is required.